RVL Pharmaceuticals plc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
RVL Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2022.
  • RVL Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$4.86M, a 481% decline year-over-year.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $41.8M.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$135M, a 3775% decline from 2020.
  • RVL Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $3.68M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $41.8M +$177M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-20
2021 -$135M -$139M -3775% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $3.68M +$8.37M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$4.69M -$8.3M -230% Jan 1, 2019 Dec 31, 2019 8-K 2021-09-08
2018 $3.6M +$26.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$23.3M Jan 1, 2017 Dec 31, 2017 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.